Indrayani Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 404.4 million compared to INR 420.53 million a year ago. Revenue was INR 405.31 million compared to INR 440.17 million a year ago. Net income was INR 55.43 million compared to INR 52.57 million a year ago. Basic earnings per share from continuing operations was INR 0.89 compared to INR 1.54 a year ago.
For the six months, sales was INR 827.53 million compared to INR 676.85 million a year ago. Revenue was INR 828.52 million compared to INR 700.43 million a year ago. Net income was INR 51.59 million compared to INR 70.45 million a year ago. Basic earnings per share from continuing operations was INR 0.83 compared to INR 2.06 a year ago. Diluted earnings per share from continuing operations was INR 0.83 compared to INR 2.06 a year ago.